Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferase

Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferase

US Patent 7078179 · Granted Jul 18, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Salts and prodrugs of 1-methyl-d-tryptophan2022
IDO inhibitors2019
Salts and prodrugs of 1-methyl-D-tryptophan2019
IDO inhibitors2018
Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan me2018
IDO inhibitors2017
Salts and prodrugs of 1-methyl-D-tryptophan2017
Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan me2017
Enhanced immunogenicity of tumor associated antigens by addition of alphagal epi2016
Enhanced immunogenicity of tumor associated antigens by addition of alphagal epi2016
Enhanced immunogenicity of tumor associated antigens by addition of alphagal epi2016
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galact2016